Evidence map›Paper›PMID 15580311›Full record

ArticleOncogene2005

The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation.

Kylene Kehn, Cynthia de la Fuente, Katharine Strouss, Reem Berro, Hua Jiang, John Brady, Renaud Mahieux, Anne Pumfery, Maria Elena Bottazzi, Fatah Kashanchi

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 111 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Mechanisms of Oncogenesis by HTLV-1 Tax.Pathogens (Basel, Switzerland) · 2020
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Kylene KehnDepartment of Biochemistry and Molecular Biology, The George Washington University School of Medicine, Washington, DC 20037, USA.
Cynthia de la Fuente
Katharine Strouss
Reem Berro
Hua Jiang
John Brady
Renaud Mahieux
Anne Pumfery
Maria Elena Bottazzi
Fatah Kashanchi
George Washington University · USNational Institutes of Health · USInstitut Pasteur · FR

Funding

HIV1 INHIBITION USING TAT PEPTIDE DERIVATIVESR01AI043894 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KASHANCHI, FATAH · 1999 to 2015
$4.4M
INTERACTION OF HTLV-I TAX WITH CELLULAR REGULATORY PROTEINSZ01BC005691 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BRADY, JOHN N. · 1996 to 2008
$2.3M
Alteration of Rb in HTLV-1 transformed cellsR21AI061560 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI KASHANCHI, FATAH · 2004 to 2005
$421k
CELL CYCLE REGULATED TRANSCRIPTION BY HIV1 TRANSACT TATR29AI044357 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KASHANCHI, FATAH · 1998 to 2002
$322k
NIAID NIH HHS AI061560NIAID NIH HHS AI43894NIAID NIH HHS AI44357
6 · The paper itself

Abstract

Human T-cell leukemia virus type-I (HTLV-I), the etiologic agent of adult T-cell leukemia (ATL), is estimated to affect 10-20 million people worldwide. The transforming ability of HTLV-I has been largely attributed to the viral protein Tax, which modulates the activity of several well-known cell cycle regulators. An important cell cycle regulator, the retinoblastoma (Rb) protein, is often inactivated in many cancers including virally induced cancers. Upon examination of Rb status, we observed a decrease in Rb protein expression in HTLV-1-infected cell lines as well as in ex vivo ATL patient samples. Transient transfection assays indicated that decreased Rb protein levels were Tax dependent. Here, we demonstrate for the first time that Tax directly associates with Rb. This interaction was localized within the B pocket of Rb and the C-terminus of Tax (aa 245-353). Within the C-terminus of Tax, we have identified an LXCXE-like motif, that when mutated resulted in the loss of Tax/Rb interaction. Furthermore, through the use of proteasome inhibitors, such as MG-132, in vivo and proteasome degradation assays in vitro, we found that Tax destabilizes the hypo-phosphorylated (active) form of Rb via the proteasome pathway. Therefore, we propose a model whereby Tax targets Rb to the proteasome by acting as a molecular bridge bringing Rb into contact with the proteasome for degradation.

Indexed as

Protein Processing, Post-TranslationalAmino Acid MotifsAmino Acid SequenceApoptosisBinding SitesCell LineGene Products, taxHumansHuman T-lymphotropic virus 1LeupeptinsMolecular Sequence DataProteasome Endopeptidase ComplexProteasome InhibitorsProtein BindingRetinoblastoma ProteinSequence Alignmentbenzyloxycarbonylleucyl-leucyl-leucine aldehydeGene Products, taxLeupeptinsProteasome Endopeptidase ComplexProteasome InhibitorsRetinoblastoma Protein

Identifiers

PMID15580311
OpenAlexW1974466602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.